Sagimet Biosciences Inc. Quarterly General and Administrative Expense in USD from Q2 2022 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.
Summary
Sagimet Biosciences Inc. quarterly/annual General and Administrative Expense history and growth rate from Q2 2022 to Q2 2024.
  • Sagimet Biosciences Inc. General and Administrative Expense for the quarter ending June 30, 2024 was $4.28M, a 79.6% increase year-over-year.
  • Sagimet Biosciences Inc. General and Administrative Expense for the twelve months ending June 30, 2024 was $16.1M.
  • Sagimet Biosciences Inc. annual General and Administrative Expense for 2023 was $13M, a 111% increase from 2022.
General and Administrative Expense, Trailing 12 Months (USD)
General and Administrative Expense, Quarterly (USD)
General and Administrative Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $16.1M $4.28M +$1.9M +79.6% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 $14.2M $3.51M +$1.23M +53.9% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $13M $3.81M Oct 1, 2023 Dec 31, 2023 10-K 2024-03-25
Q3 2023 $4.49M +$3.65M +430% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $2.38M +$1.51M +175% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 $2.28M Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q3 2022 $848K Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 $867K Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.